164 related articles for article (PubMed ID: 6807686)
1. The value of plasma prolactin levels in the prediction of the responsiveness of growth hormone secretion to bromocriptine and TRH in acromegaly.
Lamberts SW; Liuzzi A; Chiodini PG; Verde S; Klijn JG; Birkenhäger JC
Eur J Clin Invest; 1982 Apr; 12(2):151-5. PubMed ID: 6807686
[TBL] [Abstract][Full Text] [Related]
2. The higher the growth hormone response to growth hormone releasing hormone the lower the response to bromocriptine and thyrotrophin releasing hormone in acromegaly.
Smals AE; Pieters GF; Smals AG; Hermus AR; Benraad TJ; Kloppenborg PW
Clin Endocrinol (Oxf); 1987 Jul; 27(1):43-7. PubMed ID: 3115634
[TBL] [Abstract][Full Text] [Related]
3. Plasma growth hormone and prolactin responses to TRH and arginine given before and during bromocriptine therapy to patients with acromegaly.
Hanew K; Sasaki A; Mouri T; Yoshinaga K
Acta Endocrinol (Copenh); 1980 Nov; 95(3):298-307. PubMed ID: 6776756
[No Abstract] [Full Text] [Related]
4. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
5. Long-term bromocriptine therapy and predictive tests in acromegaly.
Karashima T; Kato K; Nawata H; Ikuyama S; Ibayashi H; Okamura K; Shiroozu A; Nakashima T; Fujishima M
Endocrinol Jpn; 1986 Apr; 33(2):163-7. PubMed ID: 3093202
[TBL] [Abstract][Full Text] [Related]
6. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
7. [Response of growth hormone to sandostatin and bromocriptine and prognostic value of prolactin levels in serum and thyroliberin test in patients with active acromegaly].
Gasińska T; Nowak S
Endokrynol Pol; 1993; 44(4):455-65. PubMed ID: 8055814
[TBL] [Abstract][Full Text] [Related]
8. Changes in growth hormone (GH) secretion induced by human pancreatic GH releasing hormone-44 in acromegaly: a comparison with thyrotropin-releasing hormone and bromocriptine.
Chiodini PG; Liuzzi A; Dallabonzana D; Oppizzi G; Verde GG
J Clin Endocrinol Metab; 1985 Jan; 60(1):48-52. PubMed ID: 3917270
[TBL] [Abstract][Full Text] [Related]
9. The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex.
van der Lely AJ; Harris AG; Lamberts SW
Clin Endocrinol (Oxf); 1992 Aug; 37(2):181-5. PubMed ID: 1395069
[TBL] [Abstract][Full Text] [Related]
10. Changes in plasma GH levels and clinical activity during bromocriptine therapy in acromegaly. The value of predictive tests.
Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
Acta Endocrinol (Copenh); 1984 Jun; 106(2):175-83. PubMed ID: 6145276
[TBL] [Abstract][Full Text] [Related]
11. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
Ishibashi M; Yamaji T; Kosaka K
J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
[TBL] [Abstract][Full Text] [Related]
12. The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.
Hanew K; Sugawara A; Shimizu Y; Sato S; Sasaki A; Tazawa S; Ishii K; Saitoh T; Saso S; Yoshinaga K
Endocrinol Jpn; 1989 Jun; 36(3):429-38. PubMed ID: 2510991
[TBL] [Abstract][Full Text] [Related]
13. Bromocriptine does not alter growth hormone (GH) responsiveness to GH-releasing hormone in acromegaly.
Cozzi R; Dallabonzana D; Oppizzi G; Verde G; Liuzzi A; Chiodini PG
J Clin Endocrinol Metab; 1986 Mar; 62(3):601-4. PubMed ID: 3080469
[TBL] [Abstract][Full Text] [Related]
14. Bromocriptine suppression of TRH-stimulated prolactin and thyrotrophin release and accompanying inhibition of bromocriptine induced growth hormone release by TRH in normal man.
Brown PM; Bacchus R; Sachs L; Sönksen PH; Wheeler M
Clin Endocrinol (Oxf); 1979 May; 10(5):481-8. PubMed ID: 113143
[TBL] [Abstract][Full Text] [Related]
15. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
16. Distinctive features of prolactin secretion in acromegalic patients with hyperprolactinaemia.
Serri O; Robert F; Comtois R; Jilwan N; Beauregard H; Hardy J; Somma M
Clin Endocrinol (Oxf); 1987 Oct; 27(4):429-36. PubMed ID: 3124991
[TBL] [Abstract][Full Text] [Related]
17. Thyrotropin-releasing hormone increases serum levels of growth hormone-releasing hormone and growth hormone in patients with acromegaly.
Hulting AL; Theodorsson E; Werner S
J Intern Med; 1992 Sep; 232(3):229-35. PubMed ID: 1402619
[TBL] [Abstract][Full Text] [Related]
18. Abnormal growth hormone responses to CB-154 and thyrotropin-releasing hormone (TRH) in patients with acromegaly.
Hanew K; Aida M; Sasaki A; Mouri T; Yoshinaga K
Tohoku J Exp Med; 1979 Jan; 127(1):53-62. PubMed ID: 104407
[TBL] [Abstract][Full Text] [Related]
19. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly.
Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H
Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344
[TBL] [Abstract][Full Text] [Related]
20. Effect of bromocriptine on serum hormones in acromegaly.
Carlson HE; Levin SR; Braunstein GD; Spencer EM; Wilson SE; Hershman JM
Horm Res; 1984; 19(3):142-52. PubMed ID: 6425186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
